FUSION PHARMACEUTICALS INC

CUSIP: 36118A100 Class: Foreign Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 3,122,770 Value ($000) $30,010 Avg Close — Range —
Q3 2023
Shares 3,122,770 Value ($000) $8,119 Avg Close — Range —
Q2 2023
Shares 3,122,770 Value ($000) $14,583 Avg Close — Range —
Q1 2023
Shares 3,122,770 Value ($000) $11,773 Avg Close — Range —
Q4 2022
Shares 3,224,770 Value ($000) $10,158 Avg Close — Range —
Q3 2022
Shares 3,224,770 Value ($000) $9,707 Avg Close — Range —
Q2 2022
Shares 3,224,770 Value ($000) $8,030 Avg Close — Range —
Q1 2022
Shares 3,224,770 Value ($000) $25,056 Avg Close — Range —
Q4 2021
Shares 3,224,770 Value ($000) $13,447 Avg Close — Range —
Q3 2021
Shares 3,224,770 Value ($000) $25,540 Avg Close — Range —
Q2 2021
Shares 3,224,770 Value ($000) $26,056 Avg Close — Range —
Q1 2021
Shares 3,224,770 Value ($000) $34,570 Avg Close — Range —
Q4 2020
Shares 3,224,770 Value ($000) $37,891 Avg Close — Range —
Q3 2020
Shares 3,224,770 Value ($000) $38,762 Avg Close — Range —
Q2 2020
Shares 3,224,770 Value ($000) $56,337 Avg Close — Range —